Results 161 to 170 of about 6,924,662 (223)

EFFECT OF REACTION ON OPHTHALMIC SOLUTIONS

Archives of Ophthalmology, 1933
The effect of drugs introduced into the conjunctival sac in the form of solutions is modified by a number of factors. One of the most important of these is their immediate dilution by tears always present in the sac and by those which rapidly reach it in response to the stimulation afforded by any chemical irritant.
Sanford R. Gifford, R. Denton Smith
openaire   +2 more sources

Comparative In Vitro Toxicology Study of Travoprost Polyquad-preserved, Travoprost BAK-preserved, and Latanoprost BAK-preserved Ophthalmic Solutions on Human Conjunctival Epithelial Cells

Current Eye Research, 2011
Purpose: To compare the toxicological profile of a new formulation of travoprost 0.004% ophthalmic solution (travoprost PQ), containing the preservative polyquaternium-1(PQ, polyquad), with the commercially available formulation of benzalkonium chloride (
F. Brignole-Baudouin, L. Riancho, Hong Liang, C. Baudouin   +3 more
semanticscholar   +1 more source

Extemporaneous Preparation of Antibiotic Ophthalmic Solutions

Journal of the American Pharmaceutical Association (1996), 1996
Until the introduction of ocular ciprofloxacin, the standard of practice in treating bacterial corneal ulcers required topical antibiotic ophthalmic solutions that were either not commercially available or not available in the higher concentrations needed.
Raymond W. Hammond, William Edmondson, Holly Fisher McClung, Timothy P. Walker   +3 more
openaire   +3 more sources

Ketorolac 0.45% Ophthalmic Solution

Drugs & Aging, 2011
Ketorolac 0.45% ophthalmic solution is a topical NSAID indicated in the US for the treatment of ocular pain and inflammation following cataract surgery. In animal studies, the ocular relative bioavailability of single-dose topical ketorolac 0.45% ophthalmic solution was 2- to 3-fold higher than that of ketorolac 0.4% ophthalmic solution.
openaire   +3 more sources

Buffered Ophthalmic Solutions of Silver Nitrate*

Journal of the American Pharmaceutical Association (Scientific ed.), 1955
One per cent silver nitrate solutions have been prepared in an acetate buffer at pH 6.0 and have been shown to remain stable for as long as two years.A simple colorimetric method using bromcresol purple as the indicator has been used to detect increased acidity in the solutions.This dye is especially sensitive in the range of pH 5.8 to 6.0, the ...
Walter F. Charnicki, Mary L. Kober
openaire   +3 more sources

Self-Sterilizing Ophthalmic Solutions

Journal of the American Pharmaceutical Association (Practical Pharmacy ed.), 1953
Phenylmercuric nitrate and benzalkonium chloride, in proper solutions are are recommended as effective antibacterial agents for ophthalmic medication.
Harry W Hind, Ivan J. Szekely
openaire   +2 more sources

Bimatoprost ophthalmic solution in facial vitiligo

Journal of Cosmetic Dermatology, 2017
SummaryBackgroundVitiligo is one of the commonest pigmentary disorders characterized by destruction of melanocytes.AimTo evaluate the efficacy of topical bimatoprost ophthalmic solution in stable facial vitiligo.Material and methodsEight cases of stable facial vitiligo were treated with bimatoprost 0.03% ophthalmic solution once daily for 12 weeks ...
Abhijeet K. Jha, Smita Prasad, Rajesh Sinha   +2 more
openaire   +2 more sources

Stability of fortified cefazolin ophthalmic solutions prepared in artificial tears containing surfactant-based versus oxidant-based preservatives.

Journal of Ocular Pharmacology and Therapeutics, 2010
OBJECTIVE The aim of this study was to investigate the stability of fortified cefazolin sodium ophthalmic solutions (50 mg mL⁻¹) extemporaneously prepared in commercial artificial tears containing 2 different types of preservatives, namely the ...
T. Rojanarata, Junlathip Tankul, Chayanee Woranaipinich, Paweena Potawanich, S. Plianwong, Sirinart Sakulma, Choedchai Saehuan   +6 more
semanticscholar   +1 more source

pH dependent spectral properties of sodium fluorescein ophthalmic solutions revisited

Ophthalmic & physiological optics, 2010
Purpose:  To re‐assess and further quantify the pH‐related changes in the absorbance and fluorescence emission spectra of sodium fluorescein in buffered aqueous solutions.
M. Doughty
semanticscholar   +1 more source

Ocular Penetration and Pharmacokinetics of Topical Gatifloxacin 0.3% and Moxifloxacin 0.5% Ophthalmic Solutions After Keratoplasty

Cornea, 2008
Purpose: To compare the corneal and aqueous penetration and pharmacokinetics of gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions and their effect on corneal reepithelialization after penetrating keratoplasty. Methods: In this randomized, open-
E. Holland, S. Lane, Terry Kim, M. Raizman, S. Dunn   +4 more
semanticscholar   +1 more source